A (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate written confirmation ((17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate WC) is an official document issued by a regulatory agency to a (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate manufacturer, verifying that the manufacturing facility of a (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate APIs or (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate finished pharmaceutical products to another nation, regulatory agencies frequently require a (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate WC (written confirmation) as part of the regulatory process.
										click here to find a list of (17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate suppliers with Written Confirmation (WC) on PharmaCompass.